Article Sidebar

PDF
Date Published: 17/06/2022
Abstract Views: 347
Views PDF: 196
DOI: https://doi.org/10.51298/vmj.v513i2.2479
Issue
Vol. 513 No. 2 (2022)
Section
Các bài báo
How to Cite
Công Long, N. ., & Thị Minh Ngọc, N. . (2022). EVALUATED ON BLOODSTREAM INFECTION, CLINICAL FEATURE AND SUB-CLINICAL IN CIRRHOTIC PATIENTS. Vietnam Medical Journal, 513(2). https://doi.org/10.51298/vmj.v513i2.2479

EVALUATED ON BLOODSTREAM INFECTION, CLINICAL FEATURE AND SUB-CLINICAL IN CIRRHOTIC PATIENTS

Nguyễn Công Long1,, Nguyễn Thị Minh Ngọc1
1 Department of Gastroenterology and Hepatology, Bach Mai

Main Article Content

Abstract

Objectives: The aim of this study was the evaluation of bloodstream infection, clinical features and subclinical of liver cirrhosis patients. Method: A total of 37 patients were enrolled with cirrhosis from 01/2018 to 7/2020 in Bachmai hospital. Results: Mean age at diagnosis was 50 years, 32(86.5%) were male. Common causes of cirrhosis are alcohol, hepatitis B combined with alcoholic accounted for 55.3%, 23.7%, respectively. 68.4% of patients were diagnosed in Child-pugh B stages. In addition, the majority of bacterial infection was Escherichia coli. Mortality rate after one month was 18.4% Conclusion: Our data suggest that improved prevention bacterial infections are urgently needed in the liver cirrhosis patients.

Article Details

Keywords

Liver Cirrhosis, Bloodstream infections, Bacterial infections

References

1. Albillos A, Lario M, Álvarez-Mon M: Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. Journal of hepatology 2014, 61(6):1385-1396.
2. Wiest R, Lawson M, Geuking M: Pathological bacterial translocation in liver cirrhosis. Journal of hepatology 2014, 60(1):197-209.
3. Huelin P, Piano S, Solà E, Stanco M, Solé C, Moreira R, Pose E, Fasolato S, Fabrellas N, de Prada G et al: Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017, 15(3):438-445.e435.
4. Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A et al: Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology (Baltimore, Md) 2012, 55(5):1551-1561.
5. Merli M, Lucidi C, Di Gregorio V, Falcone M, Giannelli V, Lattanzi B, Giusto M, Ceccarelli G, Farcomeni A, Riggio O et al: The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. PLoS One 2015, 10(5):e0127448-e0127448.
6. Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M et al: Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. Gastroenterology 2019, 156(5):1368-1380.e1310.